Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Study of Novel Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously Treated With an Anthracycline and a Taxane

NCT00082433 is registered in ClinicalTrials.gov with R-Pharm as lead sponsor.

NCT NCT00082433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00082433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Study of Novel Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously Treated With an Anthracycline and a Taxane
Lead sponsor
R-Pharm
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2003
Completion date
March 31, 2008
Enrollment
1,221 (actual)
Sites
186

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cancer